Address |
56 Delhi Road North Ryde New South Wales (NSW) 2113 Australia |
Employees | - |
Website | http://www.biotron.com.au |
Updated | 07/08/2019 |
Biotron Ltd. is a clinical stage Australian biotechnology company. It engages in developing and commercializing a novel small molecule approach that has the potential to treat a number of serious viral diseases. The company's technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus. |